You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Change formulations without dose titration


Keppra offers instant changeability between oral and IV formulations, without the need for dose titration1

Dose titration and therapeutic drug monitoring are not recommended for Keppra1

The represented diagram is only for illustrative purposes, not a dosing recommendation.

Please refer to full prescribing information for dosing information.

*There is no experience with administration of intravenous levetiracetam for periods longer than 4 days.1

The represented diagram is only for illustrative purposes, not a dosing recommendation.

Please refer to full prescribing information for dosing information.

*There is no experience with administration of intravenous levetiracetam for periods longer than 4 days.1

The represented diagram is only for illustrative purposes, not a dosing recommendation.

Please refer to full prescribing information for dosing information.

*There is no experience with administration of intravenous levetiracetam for periods longer than 4 days.1

Read more about Keppra

Abbreviations

IV: intravenous.

References

  1. Levetiracetam. Non Central Data Sheet Version Number: 10. Version Date: 6 January 2020.

GSK shall not be liable for any damages, claims, liabilities, costs or obligations arising from the use or misuse of information provided herein. 
For safety information on GSK products or to report an Adverse Event, please contact the toll free line 
0800 CALL GSK (0800 2255 475) or email aereporting.ng@gsk.com 
Full prescribing information is available on request on www.gskpro.com
Please note that it may take up to 10 days to process your request. If you need further assistance contact 
GSK House, 1 Industrial Avenue llupeju, Lagos or via email at customercare_ph_nigeria@gsk.com
GlaxoSmithKline Pharmaceutical Nigeria Ltd, 1 Industrial Avenue, llupeju, Lagos 234-1-271 1000 
©2020 GSK group of companies or its licensor 
Trade marks are owned by or licensed to the GSK group of companies

Keppra is a registered trademark of the GlaxoSmithKline group of companies

PM-NG-LVT-WCNT-200004 Date of preparation: November 2020.